Nephropro Dmss Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.92 M
About Nephropro Dmss
Nephropro Dmss Private Limited (NDPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 February 2020 (Four years and 11 months 26 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹4.92 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Reena Adiraju and Sairam Adiraju serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85100TG2020PTC139223
-
Company No.
139223
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Feb 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Nephropro Dmss?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sairam Adiraju
|
Director | 13-Feb-2020 | Current |
|
Reena Adiraju
|
Director | 13-Feb-2020 | Current |
Financial Performance of Nephropro Dmss.
Nephropro Dmss Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nephropro Dmss?
In 2021, Nephropro Dmss had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.92 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.33 Cr
- Hdfc Bank Limited : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2021 | Axis Bank Limited | ₹3.26 M | Satisfied |
| 16 Mar 2021 | Hdfc Bank Limited | ₹1.67 M | Satisfied |
How Many Employees Work at Nephropro Dmss?
Unlock and access historical data on people associated with Nephropro Dmss, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nephropro Dmss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephropro Dmss's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.